RxDoctor Payments Data

Keiton Johnson, PA

Family Medicine · Idaho Falls, IDNPI 1851903702

Payments from drug & device makers

$3,990in general payments, 2019–2025

Across 198 payments — averaging $20.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Amgen$342
  • Novo Nordisk$294
  • AstraZeneca$234
  • Phathom Pharmaceuticals, Inc.$166
  • GSK$156
  • plus $1K from 31 others

What the payments were for

  • Food & beverage$3,986100%
  • Education$40%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,990 in reported general payments places this provider in the 90th percentile of 803 family medicine providers in Idaho.

See all family medicine providers in Idaho

Medicare billing

Part B allowed, 2024
$37,552
Medicare patients
209
Services billed
734

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban67$46,362
FarxigaDapagliflozin Propanediol69$43,731
Trelegy ElliptaFluticasone/Umeclidin/Vilanter51$36,899
Ondansetron Hcl41$24,416
Aripiprazole88$22,887
MounjaroTirzepatide23$22,514
OzempicSemaglutide21$22,116
TrulicityDulaglutide15$13,752
JanuviaSitagliptin Phosphate17$13,251
XareltoRivaroxaban19$12,597
Breo ElliptaFluticasone/Vilanterol19$8,505
Aimovig AutoinjectorErenumab-Aooe11$7,930
MovantikNaloxegol Oxalate22$7,892
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$7,161
Atomoxetine Hcl18$6,435

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$234$50,89180 claims
PfizerEliquis$72$46,36267 claims
GSKTrelegy Ellipta, Breo Ellipta$156$45,40470 claims
Lilly USA, LLCMounjaro, Trulicity, Olanzapine$122$39,48857 claims
Novo NordiskOzempic$294$22,11621 claims
Johnson & JohnsonXarelto$38$12,59719 claims
Astellas Pharma US IncMyrbetriq$103$5,27812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 803 family medicine providers in Idaho.

Other family medicine in Idaho Falls

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →